English
简体中文
Total: £ 56.28
Published Date: 2025-06-24 | Pages: 115 | Tables: 102 | Pharma & Healthcare
In 2024, the global market size of Oncolytic Virus was estimated to be worth US$ 19.4 million and is forecast to reach approximately US$ 30.5 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus.
The Oncolytic Virus market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncolytic Virus market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncolytic Virus companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Amgen
Shanghai Sunway Biotech
Segment by Type
Imlygic
Oncorine
Others
Segment by Application
Melanoma
Other Cancers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Oncolytic Virus in global and regional level.
Chapter 3: Detailed analysis of Oncolytic Virus company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncolytic Virus revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Oncolytic Virus Product Introduction
1.2 Market by Type
1.2.1 Global Oncolytic Virus Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Imlygic
1.2.3 Oncorine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncolytic Virus Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Melanoma
1.3.3 Other Cancers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oncolytic Virus Market Size Estimates and Forecasts
2.2 Oncolytic Virus Market Size by Region: 2024 Versus 2031
2.2.1 Global Oncolytic Virus Revenue by Region: 2020-2025
2.2.2 Global Oncolytic Virus Revenue Forecast by Region (2026-2031)
2.2.3 Global Oncolytic Virus Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Oncolytic Virus Revenue by Type (2020-2031)
3.1.2 Global Oncolytic Virus Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Oncolytic Virus Revenue by Application (2020-2031)
3.2.2 Global Oncolytic Virus Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Imlygic of Oncolytic Virus Revenue Market Share by Application
3.3.2 Oncorine of Oncolytic Virus Revenue Market Share by Application
3.3.3 Others of Oncolytic Virus Revenue Market Share by Application
4 Global Oncolytic Virus by Company
4.1 Global Oncolytic Virus Revenue by Company (2020-2025)
4.2 Global Oncolytic Virus Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Oncolytic Virus Companies around the World: Ranking by Revenue
4.3.2 Global Oncolytic Virus Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Oncolytic Virus Companies Headquarters & Product Type
4.4.1 Global Oncolytic Virus Companies Headquarters
4.4.2 Date of International Companies Enter into Oncolytic Virus Market
4.4.3 Global Oncolytic Virus Companies Product & Service
4.4.4 Imlygic Revenue Market Share of Oncolytic Virus by Company
4.5 Global Oncolytic Virus Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Amgen
5.1.1 Amgen Corporation Information
5.1.2 Amgen Description, Business Overview
5.1.3 Amgen Oncolytic Virus Products Offered
5.1.4 Amgen Oncolytic Virus Revenue and Gross Margin (2020-2025)
5.1.5 Amgen Oncolytic Virus Revenue by Product in 2024
5.1.6 Amgen Oncolytic Virus Revenue by Application in 2024
5.1.7 Amgen Oncolytic Virus Revenue by Geographic Area in 2024
5.1.8 Amgen Recent Developments
5.2 Shanghai Sunway Biotech
5.2.1 Shanghai Sunway Biotech Corporation Information
5.2.2 Shanghai Sunway Biotech Description, Business Overview
5.2.3 Shanghai Sunway Biotech Oncolytic Virus Products Offered
5.2.4 Shanghai Sunway Biotech Oncolytic Virus Revenue and Gross Margin (2020-2025)
5.2.5 Shanghai Sunway Biotech Oncolytic Virus Revenue by Product in 2024
5.2.6 Shanghai Sunway Biotech Oncolytic Virus Revenue by Application in 2024
5.2.7 Shanghai Sunway Biotech Oncolytic Virus Revenue by Geographic Area in 2024
5.2.8 Shanghai Sunway Biotech Recent Developments
6 North America
6.1 North America Oncolytic Virus Market Size YoY Growth 2020-2031
6.2 North America Oncolytic Virus Market Facts & Figures by Country (2020-2031)
6.3 North America Oncolytic Virus Revenue by Type (2020-2025)
6.4 North America Oncolytic Virus Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Oncolytic Virus Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Oncolytic Virus Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Oncolytic Virus Revenue by Type (2020-2025)
7.4 Asia-Pacific Oncolytic Virus Revenue by Application (2020-2025)
8 Europe
8.1 Europe Oncolytic Virus Market Size YoY Growth 2020-2031
8.2 Europe Oncolytic Virus Market Facts & Figures by Country (2020-2031)
8.3 Europe Oncolytic Virus Revenue by Type (2020-2025)
8.4 Europe Oncolytic Virus Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Oncolytic Virus Market Size YoY Growth 2020-2031
9.2 Latin America Oncolytic Virus Market Facts & Figures by Country (2020-2031)
9.3 Latin America Oncolytic Virus Revenue by Type (2020-2025)
9.4 Latin America Oncolytic Virus Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Oncolytic Virus Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Oncolytic Virus Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Oncolytic Virus Revenue by Type (2020-2025)
10.4 Middle East and Africa Oncolytic Virus Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Oncolytic Virus Supply Chain Analysis
11.2 Oncolytic Virus Key Raw Materials and Upstream Suppliers
11.3 Oncolytic Virus Clients Analysis
11.4 Oncolytic Virus Sales Channel and Sales Model Analysis
11.4.1 Oncolytic Virus Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Oncolytic Virus Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Oncolytic Virus Distributors
12 Oncolytic Virus Market Dynamics
12.1 Oncolytic Virus Industry Trends
12.2 Oncolytic Virus Market Drivers
12.3 Oncolytic Virus Market Challenges
12.4 Oncolytic Virus Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Oncolytic Virus Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Oncolytic Virus Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Oncolytic Virus Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Oncolytic Virus Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Oncolytic Virus Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Oncolytic Virus Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Oncolytic Virus Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Oncolytic Virus Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Oncolytic Virus Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Oncolytic Virus Revenue by Company (2020-2025) & (US$ Million)
Table 11. Oncolytic Virus Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Oncolytic Virus Players by Revenue (US$ Million) in 2024
Table 13. Global Oncolytic Virus Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Oncolytic Virus by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus as of 2024)
Table 15. Global Oncolytic Virus Companies Headquarters
Table 16. Date of International Companies Enter into Oncolytic Virus Market
Table 17. Global Oncolytic Virus Companies Product & Service
Table 18. Global Oncolytic Virus Mergers & Acquisitions, Expansion Plans
Table 19. Amgen Corporation Information
Table 20. Amgen Description and Business Overview
Table 21. Amgen Oncolytic Virus Product
Table 22. Amgen Oncolytic Virus Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Amgen Revenue Proportion of Oncolytic Virus by Product in 2024
Table 24. Amgen Revenue Proportion of Oncolytic Virus by Application in 2024
Table 25. Amgen Revenue Proportion of Oncolytic Virus by Geographic Area in 2024
Table 26. Amgen Recent Developments
Table 27. Shanghai Sunway Biotech Corporation Information
Table 28. Shanghai Sunway Biotech Description and Business Overview
Table 29. Shanghai Sunway Biotech Oncolytic Virus Product
Table 30. Shanghai Sunway Biotech Oncolytic Virus Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Shanghai Sunway Biotech Revenue Proportion of Oncolytic Virus by Product in 2024
Table 32. Shanghai Sunway Biotech Revenue Proportion of Oncolytic Virus by Application in 2024
Table 33. Shanghai Sunway Biotech Revenue Proportion of Oncolytic Virus by Geographic Area in 2024
Table 34. Shanghai Sunway Biotech Recent Developments
Table 35. North America Oncolytic Virus Revenue by Country (2020-2025) & (US$ Million)
Table 36. North America Oncolytic Virus Revenue by Country (2026-2031) & (US$ Million)
Table 37. North America Oncolytic Virus Revenue by Type (2020-2025) & (US$ Million)
Table 38. North America Oncolytic Virus Revenue by Application (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Oncolytic Virus Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Oncolytic Virus Revenue by Region (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Oncolytic Virus Revenue by Type (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Oncolytic Virus Revenue by Application (2020-2025) & (US$ Million)
Table 43. Europe Oncolytic Virus Revenue by Country (2020-2025) & (US$ Million)
Table 44. Europe Oncolytic Virus Revenue by Country (2026-2031) & (US$ Million)
Table 45. Europe Oncolytic Virus Revenue by Type (2020-2025) & (US$ Million)
Table 46. Europe Oncolytic Virus Revenue by Application (2020-2025) & (US$ Million)
Table 47. Latin America Oncolytic Virus Revenue by Country (2020-2025) & (US$ Million)
Table 48. Latin America Oncolytic Virus Revenue by Country (2026-2031) & (US$ Million)
Table 49. Latin America Oncolytic Virus Revenue by Type (2020-2025) & (US$ Million)
Table 50. Latin America Oncolytic Virus Revenue by Application (2020-2025) & (US$ Million)
Table 51. Middle East and Africa Oncolytic Virus Revenue by Country (2020-2025) & (US$ Million)
Table 52. Middle East and Africa Oncolytic Virus Revenue by Country (2026-2031) & (US$ Million)
Table 53. Middle East and Africa Oncolytic Virus Revenue by Type (2020-2025) & (US$ Million)
Table 54. Middle East and Africa Oncolytic Virus Revenue by Application (2020-2025) & (US$ Million)
Table 55. Oncolytic Virus Key Raw Materials, Industry Status and Trend
Table 56. Oncolytic Virus Key Raw Materials and Upstream Suppliers
Table 57. Oncolytic Virus Clients Status and Trend
Table 58. Oncolytic Virus Typical Clients
Table 59. Oncolytic Virus Distributors
Table 60. Oncolytic Virus Market Trends
Table 61. Oncolytic Virus Market Drivers
Table 62. Oncolytic Virus Market Challenges
Table 63. Oncolytic Virus Market Restraints
Table 64. Research Programs/Design for This Report
Table 65. Key Data Information from Secondary Sources
Table 66. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncolytic Virus Product Picture
Figure 2. Global Oncolytic Virus Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Oncolytic Virus Revenue Market Share by Type in 2024 & 2031
Figure 4. Imlygic Product Picture
Figure 5. Oncorine Product Picture
Figure 6. Others Product Picture
Figure 7. Global Oncolytic Virus Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Oncolytic Virus Revenue Market Share by Application in 2024 & 2031
Figure 9. Melanoma
Figure 10. Other Cancers
Figure 11. Oncolytic Virus Report Years Considered
Figure 12. Global Oncolytic Virus Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Oncolytic Virus Market Size (2020-2031) & (US$ Million)
Figure 14. Global Oncolytic Virus Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Oncolytic Virus Revenue Market Share by Region (2020-2031)
Figure 16. Global Oncolytic Virus Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Oncolytic Virus Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Imlygic of Oncolytic Virus Revenue Market Share by Application, 2024 VS 2031
Figure 19. Oncorine of Oncolytic Virus Revenue Market Share by Application, 2024 VS 2031
Figure 20. Others of Oncolytic Virus Revenue Market Share by Application, 2024 VS 2031
Figure 21. Oncolytic Virus Revenue Share by Company (2024)
Figure 22. Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Imlygic Revenue Proportion by Company in 2024
Figure 24. Oncorine Revenue Proportion by Company in 2024
Figure 25. Others Revenue Proportion by Company in 2024
Figure 26. North America Oncolytic Virus Revenue 2020-2031 (US$ Million)
Figure 27. North America Oncolytic Virus Revenue Market Share by Type (2020-2025)
Figure 28. North America Oncolytic Virus Revenue Market Share by Application (2020-2025)
Figure 29. Asia-Pacific Oncolytic Virus Revenue 2020-2031 (US$ Million)
Figure 30. Asia-Pacific Oncolytic Virus Revenue Market Share by Region (2020-2031)
Figure 31. Asia-Pacific Oncolytic Virus Revenue Market Share by Type (2020-2025)
Figure 32. Asia-Pacific Oncolytic Virus Revenue Market Share by Application (2020-2025)
Figure 33. Europe Oncolytic Virus Revenue Growth Rate 2020-2031 (US$ Million)
Figure 34. Europe Oncolytic Virus Revenue Market Share by Country (2020-2031)
Figure 35. Europe Oncolytic Virus Revenue Market Share by Type (2020-2025)
Figure 36. Europe Oncolytic Virus Revenue Market Share by Application (2020-2025)
Figure 37. Latin America Oncolytic Virus Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Latin America Oncolytic Virus Revenue Market Share by Country (2020-2031)
Figure 39. Latin America Oncolytic Virus Revenue Market Share by Type (2020-2025)
Figure 40. Latin America Oncolytic Virus Revenue Market Share by Application (2020-2025)
Figure 41. Middle East and Africa Oncolytic Virus Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Middle East and Africa Oncolytic Virus Revenue Market Share by Country (2020-2031)
Figure 43. Middle East and Africa Oncolytic Virus Revenue Market Share by Type (2020-2025)
Figure 44. Middle East and Africa Oncolytic Virus Revenue Market Share by Application (2020-2025)
Figure 45. Oncolytic Virus Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Oncolytic Virus Raw Materials by Region in 2024
Figure 47. Oncolytic Virus Distribution Channels
Figure 48. Global Oncolytic Virus Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 49. Global Oncolytic Virus Percentage 2020-2031: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
